FDA Approves Weight Loss Drug Zepbound for Sleep Apnea in Adults
FDA Approves Weight Loss Drug Zepbound for Sleep Apnea in Adults In a groundbreaking decision, the Food and Drug Administration (FDA) has approved the weight loss drug Zepbound, specifically for the treatment of obstructive sleep apnea (OSA) in adults with obesity. This marks a significant advancement in the management of sleep disorders, particularly for individuals […]
FDA Approves Weight Loss Drug Zepbound for Sleep Apnea in Adults Read More »